Evidence map›Paper›PMID 36051638›Full record

ArticleUrology practice2022

Appropriateness Criteria for Ureteral Stent Omission following Ureteroscopy for Urinary Stone Disease.

Spencer C Hiller, Stephanie Daignault-Newton, Ivan Rakic, Susan Linsell, Bronson Conrado, S Mohammad Jafri, Ronald Rubenstein, Mazen Abdelhady, C Peter Fischer, Elena Gimenez and 15 more

Open access · greenAbstract read
In one paragraph

Article in Urology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Will the advances in retrograde intrarenal surgery extinguish percutaneous nephrolithotomy for stones larger than 2 cm?International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 1 country.

Spencer C HillerUniversity of Michigan Department of Urology, Ann Arbor MI.
Stephanie Daignault-NewtonUniversity of Michigan Department of Urology, Ann Arbor MI.
Ivan RakicWayne State University School of Medicine, Detroit MI.
Susan LinsellUniversity of Michigan Department of Urology, Ann Arbor MI.
Bronson ConradoUniversity of Michigan Department of Urology, Ann Arbor MI.
S Mohammad JafriWilliam Beaumont Hospital Department of Urology, Royal Oak MI.
Ronald RubensteinWilliam Beaumont Hospital Department of Urology, Royal Oak MI.
Mazen AbdelhadyDetroit Medical Center, Department of Urology, Detroit MI.
C Peter FischerAssociates in Urology, Chelsea MI.
Elena GimenezIHA-Urology, Ypsilanti MI.
Richard SarleSparrow Medical Group, Lansing MI.
William W RobertsUniversity of Michigan Department of Urology, Ann Arbor MI.
Conrad MaitlandSherwood Medical Center, Detroit MI.
Rafid YousifLansing Institute of Urology, Lansing MI.
Robert ElginMichigan Institute of Urology, St Claire Shores MI.
Laris GalejsMichigan Institute of Urology, Howell MI.
Jeremy KonheimIHA-Urology, Ypsilanti MI.
David LeavittVattikuti Urology Institute, Henry Ford Health System, Detroit MI.
Eric StockallCapital Urological Associates, Okemos MI.
J Rene FonteraMichigan Institute of Urology, Troy MI.
J Stuart WolfDell Medical School University of Texas, Austin TX.
John M HollingsworthUniversity of Michigan Department of Urology, Ann Arbor MI.
Casey A DauwUniversity of Michigan Department of Urology, Ann Arbor MI.
Khurshid R GhaniUniversity of Michigan Department of Urology, Ann Arbor MI.
Michigan Urological Surgery Improvement Collaborative
University of Michigan · USMichigan Institute of Urology · USBeaumont Hospital, Royal Oak · USUrology Associates · USDetroit Medical Center · USHenry Ford Health System · USSparrow Hospital · USThe University of Texas at Austin · USWayne State University · US

Funding

Real-world effectiveness of preventive pharmacological therapy for patients with kidney stonesR01DK121709 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLLINGSWORTH, JOHN MALCOLM, SHAHINIAN, VAHAKN B · 2020 to 2024
$3.0M
NIDDK NIH HHS R01 DK121709
6 · The paper itself

Abstract

Objective: To bridge the gap between evidence and clinical judgement, we defined scenarios appropriate for ureteral stent omission after uncomplicated ureteroscopy (URS) using the RAND/UCLA Appropriateness Method (RAM). We retrospectively assessed rates of appropriate stent omission, with the goal to implement these criteria in clinical practice. Methods: A panel of 15 urologists from the Michigan Urological Surgery Improvement Collaborative (MUSIC) met to define uncomplicated URS and the variables that influence stent omission decision-making. Over two rounds, they scored clinical scenarios for Appropriateness Criteria (AC) for stent omission based on a combination of variables. AC were defined by median scores: 1 to 3 (inappropriate), 4 to 6 (uncertain), and 7 to 9 (appropriate). Multivariable analysis determined the association of each variable with AC scores. Uncomplicated URS cases in the MUSIC registry were assigned AC scores and stenting rates assessed. Results: Seven variables affecting stent decision-making were identified. Of the 144 scenarios, 26 (18%) were appropriate, 88 (61%) inappropriate, and 30 (21%) uncertain for stent omission. Most scenarios appropriate for omission were pre-stented (81%). Scenarios with ureteral access sheath or stones >10mm were only appropriate if pre-stented. Stenting rates of 5,181 URS cases correlated with AC scores. Stents were placed in 61% of cases appropriate for omission (practice range, 25% to 98%). Conclusion: We defined objective variables and AC for stent omission following uncomplicated URS. AC scores correlated with stenting rates but there was substantial practice variation. Our findings demonstrate that the appropriate use of stent omission is underutilized.

Indexed as

Quality ImprovementUreteral StentsUreteroscopyUrinary Stone Disease

Identifiers

PMID36051638
PMCPMC9432824
OpenAlexW4214806633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.